Early targeted therapies, such as the tyrosine kinase inhibitor erlotinib from Roche/Genentech/OSI, offered the promise of precision medicine to treat cancer at a molecular level. Oncologists ...

The Perlmutter Cancer Center at New York City-based NYU Langone Health recently launched its new Center for Molecular Oncology, naming Shridar Ganesan, MD, PhD, as director. The center will manage, ...

In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options ...

A panelist discusses how comprehensive molecular testing at MBC diagnosis, including genomic profiling and ESR1 mutation status, helps guide treatment decisions and identify potential therapeutic ...

The Marie-Josée and Henry R. Kravis Center for Molecular Oncology spans the full range of activities required to translate molecular insights into clinical innovations — from procuring and archiving ...

tissue is a critical step in molecular oncologic testing. As molecular oncology testing becomes more important for prognostic and therapeutic decision making and tissue specimens become smaller ...

In the era of precision oncology, research focused on evaluating molecular profiles and optimizing molecular testing in advanced NSCLC is increasingly crucial, particularly in low- and middle-income ...

Breakthroughs in laboratory and data science are increasing interest in blood tests to screen for cancer, with colorectal ...

Genetic testing and molecular diagnostic usage was categorized by major testing groups: infectious disease, cancer and inherited/other acquired conditions. Results: Per-person testing cost grew by ...

The "Molecular Diagnostics for Cancer: Market Forecasts by Cancer Type, Product and Place with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering. Cancer ...